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Abstract: Many veterinarians feel that feline obesity is increasing in prevalence within Japan, but are unsure as to what real rate of
obesity prevalence exists currently. The objectives of this study are twofold. First, we sought to determine the ratio of overweight/obese
cats, as determined via body condition score (BCS), based on a cross-sectional pool of healthy cats. Second, using a uniform method
of biochemical measurement for cat plasma collected all over Japan, we sought to construct cross-sectional working reference ranges of
plasma metabolites using age, BCS, and sex as classifying factors. Overall, the rate of overweight and obese cats (BCS of >3) was 56%,
whereas obese cats (BCS >4) constituted 42% of our pool. Aging leads to an increased risk of developing lipid metabolism and kidney
issues. Increases in BCS and age both carry increased risk of insulin resistance development. Moreover, increases in BCS bring about a
higher risk of developing lipid metabolism problems, which may lead to the development of high cholesterol and triglyceride lipidemia,
accompanied by higher levels of free fatty acids. Males appear to have a higher risk than females of developing higher BCS and body
weight values, in addition to higher insulin and lower adiponectin values.
Key words: Obesity, overweight, indoor only cats, obesity ratio

1. Introduction
Overweightness and obesity are major concerns for the
global companion animal population, as is the case with
humans. The American Veterinary Medical Association
reported that about 33,000 veterinarians were responsible
for diagnosing approximately 840 overweight or obese
cats and dogs in their respective animal hospitals in 1998
(1). In addition, 52% of 136 cats recruited by houseto-house survey in the United Kingdom (2) and 40%
of vet-visiting cats in Glasgow (3) were deemed to be
overweight/obese. The latest data in the United States
indicate that 19%–29% and 6%–8% of cats are overweight
and obese, respectively (4).
Many clinical veterinarians in Japan also feel that feline
obesity is increasing in prevalence within Japan. However,
with very little data or none regarding healthy domestic
cats being readily available in Japan, veterinarians are
currently unsure as to what real rate of obesity prevalence
exists. One reason for this is because owners do not feel
the necessity to bring in their overweight cats to the
animal hospital without any apparent symptom(s) of
disease. Furthermore, compounding the problem is the
fact that owners may regard overweight or obese cats as
* Correspondence: d0908@nvlu.ac.jp
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being physically appealing and cute, without truly seeing
the potential health risk associated with overweight/
obesity to their animals. For example, obesity can induce
a low-grade inflammatory response (5), and accumulated
excess fat can result in inadequate secretion of adipokines
and dysfunction in metabolic organs. In addition, feline
obesity increases the risks of diabetes mellitus, hepatic
lipidosis, neoplasia, urinary tract disease, oral cavity and
gastrointestinal disease, dermatoses, and lameness (6).
Obesity-induced dyslipidemia in cats has the same health
consequences as in humans.
As such, the objectives of this study are twofold. First,
we sought to determine the rate of overweight/obese
cats, as determined via body condition score (BCS), in
Japan, based accordingly on a cross-sectional pool of
healthy cats that were presented to 18 different veterinary
clinics across Japan. Second, using a uniform method of
biochemical measurement for cat plasma collected all
over Japan, we sought to determine plasma biochemical
parameter reference values from healthy indoor clientowned cats, using the same cross-sectional pool of healthy
cats. In doing so, we also investigated whether age, BCS,
and sex could significantly influence changes in plasma
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biochemical parameter values. In the process, crosssectional working reference ranges of plasma metabolite
values of house cats in Japan, using age, BCS, and sex
as classifying factors, could be produced and used as a
reference by clinical veterinarians.
2. Materials and methods
2.1. Animals
Over 200 cats that were presented to 18 different veterinary
clinics across Japan (Tokyo, Ibaraki, Chiba, Osaka, and
Fukuoka) from 2008 to 2013 were eligible for our study.
All animal hospitals are located in residential regions
near large urban areas. All cats were evaluated by 18
veterinarians and 27 cats were deemed to be ineligible due
to existing disorders, such as liver failure, kidney failure,
and diabetes mellitus, based on examinations and clinical
signs, and were therefore excluded from our study. Thus,
190 cats (89 females, 101 males; age, 0.6–19 years) were
actually included in our study.
Purebred cats included Abyssinian (female (F) n =
3, male (M) n = 3), American shorthair (F-7, M-15),
Chinchilla (F-3, M-2), Japanese domestic cats (F-18,
M-14), Norwegian Forest cat (M-3), Persian (F-2, M-2),
Turkish Angora (F-1, M-2), Scottish Fold (F-1, M-3),
American Curl (M-1), British shorthair (M-1), Egyptian
Mau (F-1, M-1), Exotic Shorthair (M-1), Japanese bobtail
(M-2), Maine Coon (M-1), Ocicat (F-1, M-1), Russian
Blue (M-2), Selkirk Rex (M-1), Siamese (F-1, M-1), Mix
(F-38, M-37), and unreported/unknown (F-11, M-10).
The subjects were diagnosed to be clinically healthy
according to the physical evaluation and clinical signs as
assessed by the attending veterinarian, who scored them
on a 5 point BCS scale [1, very thin; 2, underweight; 3,
ideal; 4, overweight, and 5, obese] (7), based on palpation
and inspection.
To investigate the effects of aging, cats were divided
into six age group categories based on 2010 AAFP/AAHA
Feline Life Stage Guidelines (8): kitten (0–6 months),
junior (7 months to 2 years), prime (3–6 years), mature
(7–10 years), senior (11–14 years), and geriatric (>15
years). When analyzing age as a factor, cats were divided
into 3 main groups: young (consisting of kitten and
junior animals), mature (consisting of prime and mature
animals), and elderly (consisting of senior and geriatric
animals). In addition, when analyzing BCS as a factor,
cats were originally classified according to their BCS on
a 5-point scale and then subsequently grouped into 1 of 3
main groups for our study: thin to underweight (BCS of
<3), ideal (BCS of 3), and overweight/obese (BCS of >3).
Animal body weight (BW) was measured individually at
each animal hospital.
Ethical approval was obtained from the Nippon
Veterinary and Life Science University Animal Research

Committee. Written informed consent was obtained from
the owners of the animals in this study.
2.2. Blood sampling
Postprandial blood samples (at least 4 h after the last meal)
were collected from the cervical vein into heparinized
plastic tubes. Blood samples were immediately centrifuged
at 1700 × g for 10 min at 4 °C and subsequently were stored
at –25 °C until further use.
2.3. Analysis of plasma metabolite parameters
Plasma metabolites, hormone and adipokine concentrations,
and enzyme activities were measured. Plasma glucose
(Glu), triglyceride (TG), total cholesterol (T-cho), total
protein (TP), blood urea nitrogen (BUN), and creatinine
(Cre) concentrations, as well as lactate dehydrogenase
(LDH), aspartate aminotransferase (AST), and alanine
aminotransferase (ALT) activities, were measured using
an Olympus AU680 autoanalyzer (Olympus Corporation,
Tokyo, Japan) with the manufacturer’s reagents. Free fatty
acids (FFAs), adiponectin, and insulin were determined
with an NEFA-C test (Wako Pure Chemical Industries,
Inc., Tokyo, Japan), mouse and rat adiponectin ELISA kit
(Otsuka Pharmaceutical Co., Tokyo, Japan), and an Lbis
cat insulin kit (Shibayagi Co., Gunma, Japan), respectively.
2.4. Statistical analysis
Values are expressed as means ± 95% confidence interval.
Nonparametric reference intervals (RIs) were determined
using Analyse-It statistical add-in software for Microsoft
Excel (v 4.00.1, Analyse-It Software, Ltd., Leeds, UK).
Multivariate linear regression analysis was performed
to determine the effect of age, BCS, and sex on plasma
analyses. Statistical significance was determined by
Kruskal–Wallis multiple comparison ANOVA (Dunn’s
method). All tests were performed using Sigmaplot
(Version 11.2, Build 11.2.0.5, Systat Software Inc., San
Diego, CA, USA). The significance level was set at P < 0.05.
3. Results
3.1. Prevalence of overweight/obesity
In order to determine the prevalence rate of overweight/
obesity of cats in Japan, a cross-sectional pool of 190
healthy cats that were presented to 18 different veterinary
clinics across Japan was examined. Cats were divided
into 5 different BCS categories, with BCS scores of 3, 4,
and 5 being equal to ideal, overweight, and obese body
condition. Out of 190 cats examined, 14% (27/190) were
overweight while 42% (80/190) were obese, with an overall
prevalence rate of 56% (107/190) for being overweight/
obese (Table 1).
3.2. Combined reference intervals
For reference interval calculations, all cats, including both
sexes and regardless of age or BCS, were combined. All
records, after outlier investigation, were used to determine

305

MORI et al. / Turk J Vet Anim Sci
Table 1. BCS ratio of cross-sectional pool of Japanese cats.
BCS <3

BCS 3

(n)

Rate

(n)

Rate

(n)

Rate

Kitten (0–6 months)

9

81.8%

2

18.2%

0

0.0%

Junior (7 months to 2 years)

0

0.0%

13

65.0%

7

35.0%

Prime (3–6 years)

4

6.6%

15

24.6%

42

68.9%

Mature (7–10 years)

3

5.6%

19

35.2%

32

59.3%

Senior (11–14 years)

2

6.1%

8

24.2%

23

69.7%

Geriatric (>15 years)

4

33.3%

4

33.3%

4

33.3%

Total

22

61

BCS >3

107

Obesity rate (BCS >4 (n = 80)): 42%.
Overweight and obese rate (BCS >3 (n = 107)): 56%.

95% reference intervals. Descriptive statistics (Table 2) and
visual examination (histograms provided in the Figure)
were used to explore the data. The Shapiro–Wilk test (9)
was applied to each biochemical parameter to test for the
hypothesis of normality. Since all parameters exhibited a
nonnormal distribution pattern, nonparametric reference
intervals were calculated.
3.3. Influence of age, BCS, or sex on parameter values
Table 3 lists all the P-values for each individual factor (age,
BCS, or sex) that may have had an influence on plasma
parameter values measured. Age appears to significantly
affect TG (P = 0.009), with a tendency to influence BCS
(P = 0.074). BCS appears to significantly affect BW (P <
0.001) and TG (P = 0.022), with a tendency to be affected
by age (P = 0.074). Lastly, sex has a tendency to affect LDH
(P = 0.062). Parameter reference ranges according to age
(Table 4), BCS (Table 5), and sex (Table 6) are further
elaborated.
4. Discussion
Remarkably, more than half (~56% of 190 cats) of the
vet-visiting cats in this study were overweight or obese,
which is in line with and nearly double the obesity rate
previously reported in the United Kingdom (52%) (2) and
United States (19%–29%) (4), respectively. However, the
obesity rate (BCS >4) in vet-visiting cats was ~42% (80 of
190 cats), which exceeded our expectations and is roughly
5 times the rate reported for the United States (6%–8%)
(4). There are a multitude of factors to help explain this
greater incidence of feline overweight and obesity in Japan
as compared to the United States. One major characteristic
is that the majority of cats in Japan are considered to be
indoor cats, which rarely leave their owners’ homes.

306

As of 2011, the Tokyo Metropolitan Government
Bureau of Social Welfare and Public Health reported that
1,110,000 cats were living in Tokyo, and 860,000 of them
(~77%) were indoor-only cats (10). Because it is easier for
people living in the city to have indoor-only cats than dogs,
the trend in the number of indoor cats has been steadily
rising, whereas indoor-outdoor and stray cats tend to be
steadily decreasing in Japan (10). As such, indoor-only cats
may be commonly overfed, as a sign of owner affection,
and allowed a minimum amount of exercise. Furthermore,
compounding the problem is the fact that owners may
regard overweight or obese cats as being physically
appealing and cute, without truly seeing the potential
health risk associated with overweight/obesity to their
animals. Interestingly, approximately 60% of all animals
in the prime (3–6 years), mature (7–10 years), and senior
(11–14 years) age groups were overweight or obese. This
contrasts with approximately 25% of prime (3–6 years),
mature (7–10 years), and senior (11–14 years) animals
and over 60% of junior (7 months to 2 years) animals
having ideal BCS. This would indicate that aging is an
important factor to consider in contributing to the overall
prevalence of overweight/obesity. In addition, since this
study comprised client-owned animals, standardization
of diet and housing was not possible. Instead, the animals
were kept under a variety of situations and fed a variety
of commercial diet regimens. However, due to the
large number of animals from a variety of management
conditions, we think that this is a good representation of
the cat population kept in Japan.
With very little data or none regarding healthy domestic
cats being readily available in Japan, veterinarians are
currently unsure as to what reference value ranges for
plasma metabolites should be used in healthy domestic
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Table 2. Descriptive statistics for the observations from cross-sectional pool of Japanese cats used in the reference interval.

Analytes

Number of
observations

Glucose
(mg/dL)

189

Insulin
(ng/mL)

130

Adiponectin
(µg/mL)

177

Triglycerides
(mg/dL)

179

Total
cholesterol (mg/dL)

180

Free fatty
116
acids (FFAs) (mEq/L)
Total protein
(g/dL)

189

BUN
(mg/dL)

189

Creatinine
(mg/dL)

189

LDH
(IU/L)

190

AST
(IU/L)

190

ALT
(IU/L)

189

Normality of
distribution

Median
Mean

Minimum value
Maximum value

Not normal

95.5

P < 0.0001

Reference values
2.5% limit
(90% CI)

97.5% limit
(90% CI)

18

55.1

266

110.4

432

(51.2–55.1)

(266–375.8)

Not normal

2.63

1.62

1.81

7

P < 0.0001

3.08

7.89

(1.62–1.81)

(7.00–7.58)

Not normal

4.05

0.02

0.32

27.69

P < 0.0001

6.48

37.14

(0.13–0.32)

(27.69–36.00)

Not normal

39

8

12.6

248.7

P < 0.0001

60.2

278

(10.1–12.6)

(248.7–261.5)

Not normal

129

44

62

242

P < 0.0001

138.5

341

(54–62)

(242-287.3)

Not normal

0.307

0.008

0.021

2.863

P < 0.0001

0.799

5.55

(0.008–0.021)

(2.863–4.443)

Not normal

7.6

3.7

6

9.9

P < 0.0001

7.72

12.5

(5.43–6)

(9.9-11.07)

Not normal

22.95

8.6

12.81

45.71

P < 0.0001

24.44

103.2

(11.6–12.81)

(45.71–59.51)

Not normal

1.31

0.56

0.83

2.64

P < 0.0001

1.38

3.26

(0.70–0.83)

(2.64–3.79)

Not normal

128.5

24

40

1150.5

P < 0.0001

229

5006

(31.9–40.0)

(1150.50–2968.30)

Not normal

27

10

16.23

124.75

P < 0.0001

35.8

201.3

(12.21–16.23)

(124.75–173.18)

Not normal

48

10

20

170.9

P < 0.0001

58.7

283

(13.2–20)

(170.9–196.2)

cats. In this study, we took the opportunity to survey and
create cross-sectional working reference value ranges
for plasma metabolites commonly used to survey and
diagnose metabolic health state. All of our plasma samples
were derived from vet-visiting cats not showing any signs
of disease, thereby providing a partial cross-sectional
glimpse of healthy cats in Japan (Table 2). We elected to
construct a working reference value range to include
overweight and obese cats, since they were deemed
to be healthy and not showing any signs of disease, to
better reflect the actual cat population encountered by
veterinarians in Japan. However, age, BCS condition, and
sex can have a profound impact on the reference value
range of plasma metabolite values in healthy cats (Table 3).

Therefore, we also examined the influence of these factors
and constructed reference value ranges according to each
factor.
Aging had meaningful impacts on adiponectin, BUN,
BCS, BW, Cre, insulin, and T-cho values (Table 4), which
would all indicate that aging animals are at a greater risk
of developing obesity-related health risks. BW and BCS
values tended to increase with age. Insulin vales were
increasing whereas adiponectin values were decreasing
with age, which are all signs of possible insulin resistance
development. Insulin resistance is frequently observed
in cats, unlike in dogs (11). Cats, with their tendency to
develop insulin resistance, are considered a good animal
model for studying the onset mechanism of metabolic
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Frequency, number of cats

Frequency, number of cats

Frequency, number of cats

mg/dL

mg/dL

mg/dL

µg/mL

Total cholesterol

Glucose

BUN

g/dL

ng/dL

mg/dL

IU/L

Total protein

Insulin

CRE

ALT

ng/dL

IU/L

mEq/L

IU/L

Tryglycerides

LDH

FFA

AST

Figure. Histograms illustrating the distribution of the observations used for the reference interval calculations for the 12 parameters described in Table 2 in a crosssectional pool of healthy cats that were presented to 18 different veterinary clinics across Japan.

Frequency, number of cats

Frequency, number of cats
Frequency, number of cats
Frequency, number of cats
Frequency, number of cats
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Table 3. Multivariate linear regression analysis.
Analyte

Age

BCS

Sex

Glucose (mg/dL)

0.947

0.329

0.471

Insulin (ng/mL)

0.804

0.672

0.728

Adiponectin (µg/mL)

0.843

0.825

Triglycerides (mg/dL)

0.009

0.022

0.615

Total cholesterol (mg/dL)

0.360

0.577

0.593

FFAs (mEq/L)

0.681

0.929

0.827

Total protein (g/dL)

0.112

0.389

0.856

BUN (mg/dL)

0.866

0.270

0.309

a

0.257
b

Creatinine (mg/dL)

0.93

0.382

0.662

LDH (IU/L)

0.658

0.597

0.062
0.225

AST (IU/L)

0.457

0.934

ALT (IU/L)

0.152

0.585

BW (kg)

0.292

<0.001

0.356

Age (years)

N/A

0.074

0.738

0.783
b

Sex

0.738

0.181

N/A

BCS (out of 5)

0.074

N/A

0.181

Values are presented as P-values for each factor.
a
: Indicates significance of age (P < 0.05) on analyte.
b
: Indicates significance of BCS (P < 0.05) on analyte.
Table 4. Reference value ranges of analytes as filtered by age category.
Analyte

Young
Kitten (0–6 months) (n = 11)
Junior (7 months to 2 years) (n = 20)

Mature
Prime (3–6 years) (n = 60)
Mature (7–10 years) (n = 54)

Elderly
Senior (11–14 years) (n = 33)
Geriatric (>15 years) (n = 12)

P-values

Glucose (mg/dL)

112.81 ± 19.95

108.05 ± 9.49

112.76 ± 18.37

0.352

Insulin (ng/mL)

2.9 ± 0.36

2.92 ± 0.31

3.43 ± 0.47b

0.034

Adiponectin (µg/mL)

8.27 ± 2.51

6.31 ± 1.43a

5.46 ± 1.50a

0.053

Triglycerides (mg/dL)

51.47 ± 11.35

95.04 ± 25.40

47.46 ± 12.39

0.139

Total cholesterol (mg/dL)

109.31 ± 9.80

139.39 ± 7.18a

154.07 ± 17.06a

<0.001

FFAs (mEq/L)

0.76 ± 0.35

0.76 ± 0.23

0.94 ± 0.42

0.476

Total protein (g/dL)

7.50 ± 0.22

7.80 ± 0.18

7.68 ± 0.33

0.312

BUN (mg/dL)

20.83 ± 1.95

22.56 ± 0.93

31.01 ± 4.46b

<0.001

Creatinine (mg/dL)

1.07 ± 0.08

1.32 ± 0.05

1.74 ± 0.17

<0.001

LDH (IU/L)

359.5 ± 213.92

151.47 ± 32.46

319 ± 222.95

0.001

AST (IU/L)

50.82 ± 15.38

29.28 ± 2.63ad

40.20 ± 9.99

0.002

a

ac

ad

ALT (IU/L)

62.29 ± 16.36

55.26 ± 5.81

62.87 ± 13.60

0.432

Age (years)

1.42 ± 0.21

6.49 ± 0.46a

13.38 ± 0.68b

<0.001

BW (kg)

3.29 ± 0.32

4.67 ± 0.34a

3.93 ± 0.54a

<0.001

BCS (out of 5)

3.08 ± 0.19

3.7 ± 0.14a

3.5 ± 0.23a

<0.001

P-values indicate significant differences in the median values among the treatment groups.
: Indicates significance when compared to the ‘Young’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
b
: Indicates significance when compared to ‘Young’ and ‘Mature’ categories (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
c
: Indicates significance when compared to ‘Mature’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
d
: Indicates significance when compared to ‘Elderly’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
a
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Table 5. Reference value ranges of analytes as filtered by BCS category.
Thin

Ideal

Overweight

BCS <3 (n = 22)

BCS 3 (n = 61)

BCS >3 (n = 107)

Glucose (mg/dL)

94.32 ± 18.61

109.82 ± 13.09

113.96 ± 11.17

0.075
0.001

Analyte

P-values

Insulin (ng/mL)

2.58 ± 0.42

2.55 ± 0.36

3.32 ± 0.31

Adiponectin (µg/mL)

10.37 ± 3.42

9.56 ± 2.29

3.95 ± 0.85b

Triglycerides (mg/dL)

44.77 ± 14.52

40.31 ± 7.34

76.87 ± 13.59

0.001

Total cholesterol (mg/dL)

114.59 ± 14.89

118.26 ± 9.16

154.51 ± 8.58b

<0.001

FFAs (mEq/L)

0.43 ± 0.27

0.98 ± 0.29

0.75 ± 0.29

0.021

Total protein (g/dL)

8.21 ± 0.58

7.63 ± 0.28

7.67 ± 0.15

0.194

BUN (mg/dL)

25.24 ± 5.83

23.98 ± 1.78

24.45 ± 1.86

0.496

Creatinine (mg/dL)

1.43 ± 0.31

1.29 ± 0.08

1.43 ± 0.08

0.069

LDH (IU/L)

339.55 ± 179.88

332.54 ± 195.75

144.66 ± 19.68b

0.02

AST (IU/L)

55.16 ± 19.79c

36.07 ± 5.96

31.32 ± 4.48

<0.001

ALT (IU/L)

69.64 ± 29.76

59.34 ± 11.46

58.06 ± 6.36

0.776

b

<0.001
b

a

Age (years)

6.52 ± 2.80

6.41 ± 1.15

7.88 ± 0.77

0.03

BW(kg)

3.08 ± 0.27

3.54 ± 0.21

5.46 ± 0.40b

<0.001

BCS (out of 5)

2.38 ± 0.12

3.00 ± 0.00

4.11 ± 0.10

<0.001

b

a

b

P-values indicate significant differences in the median values among the treatment groups.
a
: Indicates significance when compared to the ‘Thin’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
b
: Indicates significance when compared to ‘Thin’ and ‘Ideal’ categories (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
c
: Indicates significance when compared to ‘Ideal’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).

Table 6. Reference value ranges of analytes as filtered by sex.
Analyte

Females (n = 89)

Males (n = 101)

P-values

Glucose (mg/dL)

110.42 ± 11.17

110.38 ± 11.15

0.667

Insulin (ng/mL)

2.85 ± 0.32

3.23 ± 0.33b

0.086

Adiponectin (µg/mL)

8.19 ± 1.78

4.93 ± 1.06

<0.001

Triglycerides (mg/dL)

72.57 ± 19.70

69.93 ± 14.32

0.747

a

Total cholesterol (mg/dL)

114.59 ± 14.89

140.56 ± 8.25

0.128

FFAs (mEq/L)

0.77 ± 0.24

0.80 ± 0.26

0.884

Total protein (g/dL)

7.69± 0.18

7.74 ± 0.21

0.719

BUN (mg/dL)

25.30 ± 1.75

Creatinine (mg/dL)

1.37 ± 0.09

c

23.57 ± 2.02

0.075

1.39 ± 0.09

0.928

LDH (IU/L)

259.50 ± 132.71

201.61 ± 52.17

0.256

AST (IU/L)

37.25 ± 5.44

34.27 ± 5.74a

0.041

ALT (IU/L)

65.40 ± 10.66

54.92 ± 6.51

0.129

Age (years)

7.08 ± 0.98

7.42 ± 0.86

0.562

BW(kg)

3.52 ± 0.25

4.91 ± 0.38a

<0.001

BCS (out of 5)

3.34 ± 0.15

3.73 ± 0.16a

<0.001

P-values indicate significant differences in the median values among the treatment groups.
: Indicates significance when compared to the ‘Female’ category (P < 0.05; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
b
: Indicates significance when compared to ‘Female’ category (P < 0.10; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
c
: Indicates significance when compared to ‘Male’ category (P < 0.10; Kruskal–Wallis multiple comparison ANOVA (Dunn’s method)).
a
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syndrome in humans (12). In addition, aging appears to
have a detrimental effect on lipid and renal metabolism,
which may lead to the development of high cholesterol
lipidemia and kidney failure with aging in healthy cats.
T-Cho, BUN, and Cre values of healthy cats were markedly
elevated with aging, with these values being highest in the
geriatric group. In addition, ALT, AST, LDH, triglycerides,
and total protein values seem unaffected by aging in
healthy cats, unlike in healthy dogs.
BCS also had a meaningful impact on adiponectin,
BW, FFAs, insulin, T-cho, and triglyceride values (Table 5),
which would all indicate that healthy animals with high
BCS values are at a greater risk of developing obesityrelated health risks. BW values tended to increase with BCS.
Insulin vales were also increasing whereas adiponectin
values were decreasing with BCS, which are all signs of
possible insulin resistance development. In addition, BCS
appears to have a detrimental effect on lipid metabolism,
which may lead to the development of high cholesterol
and triglyceride lipidemia, accompanied by higher levels
of FFAs, which would exacerbate the condition.
Lastly, sex had a meaningful impact on adiponectin,
BCS, BW, and insulin values (Table 6). Healthy male cats
were heavier in weight than females and also tended to
have corresponding higher BCS values. In addition, male
cats had higher insulin and lower adiponectin values
than female cats, which would indicate a higher risk of
developing insulin resistance. In addition, male cats had
a tendency to have higher total cholesterol levels, which
might be indicative of a higher risk of also developing high
cholesterol lipidemia, which would be corroborated by
greater BW and BCS values in males than females.
Overall, this study has a number of limitations. First,
the data were gathered from only 18 practices across
Japan, and henceforth we should have recruited more
practices into our study to increase the amount of samples.
Collecting more samples would help increase the accuracy
of the working parameter reference value ranges, in
addition to allowing us to possibly factor in breed influence
on parameter values. However, since the collected samples
were from cats living in both city and rural areas, our
results accurately reflect a representative cross-section of
the current prevalence rate of overweight and obese cats
in Japan. Second, we were unable to collect information
regarding the reproductive status of cats. Previous risk
factors found in overweight or obese cats can be divided
into factors such as sex, reproductive status, and breed
(13–15). These factors have been postulated to contribute
directly or indirectly to positive energy balance and
subsequent weight gain. In future experiments, we should
collect samples from healthier cats, with a focus on noting
reproductive status, and continue to investigate overweight
and obese rates in healthy Japanese cats. Lastly, the effect

of cat breed on parameter values could not be factored. We
did not have a sufficient amount of samples collected to
examine breed influence. Forty percent of our samples were
from mixed cats and 11% were unknown; henceforth, our
parameter reference range values are currently dominated
by mixed-breed animals. Breed has been documented as
a risk factor found in overweight or obese cats (15) and
has been postulated to contribute directly or indirectly to
positive energy balance and subsequent weight gain. In
fact, breed has been implicated as a possible predilection
for aberrations in lipid metabolism, as in the case with
Burmese animals (16). Therefore, in the future, we hope to
be able to collect more samples and be able to have equal
amounts of samples from various breeds for better overall
representation. Ideally, we would like to produce working
parameter reference values based accordingly on age, BCS,
breed, sex, or reproductive status in the future.
In conclusion, the rate of overweight and obese cats
(BCS >3) in Japan was ~56%, with obese cats (BCS >4)
accounting for 42% of all cats surveyed in our study.
When examining a cross-section pool of healthy cats in
Japan, aging, BCS, and sex were observed to all have an
impact on certain plasma metabolite values. Aging is very
important and it is necessary for owners to consider and
ensure adequate contents/quantity of diet and exercise
to meet each cat’s requirement, depending on their ages.
Weight management in Japanese cats appears to be
extremely important starting at prime age (3–6 years).
In addition, there is a necessity for owners to understand
that Japanese cats have increased rates of developing lipid
metabolism and kidney issues associated with aging.
Increases in BCS and age both carry increased risk of
insulin resistance developing in healthy cats. Moreover,
increases in BCS value bring about higher risks of
developing lipid metabolism problems, which may lead
to the development of high cholesterol and triglyceride
lipidemia, accompanied by higher levels of FFAs, which
could exacerbate the condition. Lastly, males appear to
have a higher risk than females of developing higher BCS
and BW values, in addition to higher insulin and lower
adiponectin values, which might lead to a higher risk of
developing insulin resistance. In addition, male cats have
a tendency to have higher total cholesterol levels, which
might be indicative of a higher risk of also developing high
cholesterol lipidemia.
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